Cardiol Therapeutics (OTCMKTS:CRTPF) Trading 2% Higher – Still a Buy?

Cardiol Therapeutics Inc. (OTCMKTS:CRTPF)’s share price traded up 2% during trading on Wednesday . The stock traded as high as $1.0599 and last traded at $1.04. 176,576 shares changed hands during trading, an increase of 163% from the average session volume of 67,097 shares. The stock had previously closed at $1.02.

Cardiol Therapeutics Price Performance

The company’s 50-day simple moving average is $1.02 and its 200-day simple moving average is $1.07.

Cardiol Therapeutics Company Profile

Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.

Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.